There was one report about HSPB polymorphism found to be associated with NSCLC prognosis, in the US patients, it found that the CC genotype of HSPB1 rs2868371 was associated with poorer overall survival in US patients with NSCLC after radio(chemo)therapy (Xu et al., 2012). This evidence concerns the gene HSPB1 and non-small cell lung carcinoma.